Supplemental Data

Supplemental Figures
Suppl. Figure The single (L128A) and two double mutants (L128A-L131A and Y141A-L142A) were studied by far-UV CD after purification by gel filtration chromatography. The CD analyses confirmed that in all the cases the residues substitutions did not compromise the stability of the protein domain and that the protein adopted the native fold state. (B) Nano ES MS data shows that the double mutants BUBR1 L128A-L131A and Y141A-L142A have a very low affinity for the Blinkin mimic peptide compared to the WT protein. Peptide-free BUBR1 is show for comparison. (C) 1d 1 H NMR spectra of BUBR1 wild-type and bindingsite mutants (only an expansion of the up-field methyl region is shown here). Akin to the wild-type, both double-mutants exhibit ring-current shifted methyl signals indicative of tertiary structure. Some differences in chemical shifts presumably arise from Leu-Ala mutation of L128 and L142, which resonate in this region, and potentially subtle local conformational differences/loss of the Y141 ring-current in this area of the structure. (D) yeast-two hybrid experiments showed not interaction between the double mutants BUBR1 L128A-L131A and Y141A-L142A and Blinkin. Mated cells were selected in quadruple dropout (SD/-Ade/-His/-Leu/-Trp) plates containing alpha-galactosidase using protocols described in materials and methods.
Supplementary Movies 1-4. Time-lapse microscopy of BUBR1 mutants.
Movie 1. SAC function in a 3FLAG-Venus-BUBR1(WT)-expressing cell as monitored by time-lapse microscopy. The time between one frame and the next is 6 minutes. The time from the NEBD to anaphase for WT BUBR1 was 258 min.
Movie 2. SAC function in a 3FLAG-Venus-BUBR1(KEN26AAA)mutant-expressing cell as monitored by time-lapse microscopy. The time between one frame and the next is 6 minutes. The time from the NEBD to anaphase of BUBR1(KEN26AAA) was 18 min.
Movie 3. SAC function in a 3FLAG-Venus-BUBR1(L128A/L131A)mutant-expressing cell as monitored by time-lapse microscopy. The time between one frame and the next is 6 minutes. The time from the NEBD to anaphase of BUBR1(L128A/L131A) was 180 min.
Movies 4. SAC function in a 3FLAG-Venus-BUBR1(Y141A/L142A)mutant-expressing cell as monitored by time-lapse microscopy. The time between one frame and the next is 6 minutes. The time from the NEBD to anaphase of BUBR1(Y141A/L142A) was 78 min. with 0.5x YPDA and 100 μl plated on SD/-Leu/-Trp (double dropout) and SD/-Ade/-His/-Leu/-Trp (quadruple dropout) plates containing 1 mg/ml X-α-Gal (Clontech). Plates were incubated at 30 °C and growth monitored for two, three or five days. Shown plates are representative of at least three replicates performed using independent yeast transformants.
Supplemental Experimental Procedures
Mass Spectrometry-For the preparation of protein-peptide complexes, pure BUBR1 was mixed with an excess of peptide (typically 1:3 molar ratio). After 4 °C incubation of the mixture for few hours, each protein-peptide complex was purified by size exclusion chromatography in a Superdex 75 26/60 column previously equilibrated in 50 mM sodium phosphates buffer pH 6.0 containing 200 mM NaCl. Protein-peptide complex was concentrated to 9 mg/ml and flash frozen before storage at -80 °C. Samples for nano-electrospray mass spectrometry (Nano-ESI MS) were prepared by dilution of the original 220 μM stock solution to a final concentration of 45 μM and buffer exchanged to 0.2 M ammonium acetate pH 6.9 using Micro biospin chromatography columns (BioRad). High resolution mass spectroscopy measurements were recorded using a Waters LCT Premier mass spectrometer optimized for the transmission of noncovalent complexes. Typically, 3 μL solution containing BUBR1-peptides were electrosprayed from gold-coated glass capillaries. The pressures and accelerating potentials in the mass spectrometer were optimized to remove adducts while preserving non-covalent interactions. The optimum experimental conditions were obtained with a cone voltage of 87 V, capillary voltage of 1.9 kV, ion energy, 80 V; source pressure 2.7 mbar and time-of-flight analyser pressure 3.3e-7 mbar. All spectra were calibrated internally using a solution of cesium iodide (100 mg/mL). Data were processed withMassLynx 4.0 software (Waters/Micromass) with minimal smoothing and without background subtraction.
Protein expression and crystallization-BUBR1 57-220 and BUBR1 57-220 -Blinkin 208-226 fusion were expressed in E. coli BL21(DE3) Rosetta 2 cells and 2xTY broth while BUBR1 and BUBR1 57-220 -Blinkin 208-226 fusion for NMR studies were expressed in E. coli BL21(DE3) using M9 medium containing 0.1% 15 NH 4 Cl, 13 Glucose and 100 μg/ml ampicillin. Chimeric BUBR1 57-220 -Blinkin 208-226 was designed by fusion of the Blinkin gene fragment encoding for residues S208-K226 to the 5' end of the Bubr1 fragment encoding for BUBR1 using a flexible linker (aca/g-ggc/g-agt/c) 4 and expressed as a GST fusion. Cells were grown for 3 h at 25 °C following induction with 0.8 mM IPTG, suspended in 20 mM TrisHCl pH 8.0, 300 mM NaCl, 1 mM 1,4-dithiothreitol with protease inhibitor cocktail (Roche) and lysed by sonication. All purification steps were identical as those described above.
Small, single crystals were obtained after optimization of two different crystallization conditions derived from sparse matrix screenings (0.1M magnesium acetate-0.1M sodium cacodylate pH 6.0, 15% PEG 6000 and 0.1M MES pH 6.5, 25% PEG 6000) using conventional vapour diffusion methods.
Circular Dichroism-Far-UV circular dichroism spectra were recorded on an AVIV 62-S spectropolarimeter (AVIV, New Jersey, USA) previously calibrated with camphorosulfonic acid and equipped with a temperature control unit. In all experiments, spectra were recorded at 20 °C in a 0.1 cm quartz cell using an average time of 1.0 s, a step size of 0.5 nm, 1-nm bandwidth, and averaged over 20 scans. The dependence of CD signal on protein concentration was calculated by triplicate using independent samples of concentrations ranging between 50 g/ml to 600 g/ml (i.e., 2-22 M). For peptide titration experiments pure BubR1 57-220 was used at concentration 400 g/ml. After The crystal structure solution was obtained by molecular replacement method using structure of BUBR1 (PDB 2WVI) as the search probe. Crystallographic refinement was performed in REFMAC5 (Murshudov et al., 1997) . The model was improved by several rounds of refinement with REFMAC5 and manual rebuilding using COOT (Emsley and Cowtan, 2004) resulting in the final R factor of 19.3% and Rfree = 24.7% (Table I) .
Electron density maps obtained clearly showed all -helices and most of the connecting loops were readily traced. Ramachandran plot analysis using PROCHECK (Laskowski et al., 1993) shows that 98.8% residues fall in the preferred and allowed regions, and only 3 residues are present in disallowed regions.
NMR experiments -NMR experiments were performed on samples of ~200 M uniformly for the chimera. Data were processed using NMRPipe (Delaglio et al., 1995) , with reconstruction of NUS time-domain data using MDD1.6 (Jaravine et al., 2006) , and analysed in NMRView (One Moon Scientific). Assignment was aided by an NMRView module (Marchant et al., 2008) , which provided rapid input for MARS automated assignment (Jung and Zweckstetter, 2004) . Titration of BUBR1 incrementally up to 2 moles of Blinkin peptide to one mole of protein was monitored using 2D performed by quick change PCR using Pfu ultra polymerase (Stratagene) and all constructs were confirmed by DNA sequencing. Stable HeLa/FRT/Trex cell lines were generated as previously described (Nilsson et al., 2008) . Cells were seeded into 8 well ibiTreat dishes (ibidi) and synchronized with 2.5 mM Thymidine and depleted of endogenous BUBR1 using RNAi Max (Invitrogen) and 100 nM RNAi oligo. Cells were filmed in Leibovitz's L15 medium (GIBCO) on a Deltavision Core microscope (Applied Precision) using a UApo 40X/1.35 NA objective and analyzed using Softworx software.
